Related Experiment Video
Updated: Jun 13, 2026

07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Targeting mitochondria for cancer therapy.
Simone Fulda1, Lorenzo Galluzzi, Guido Kroemer
1University Children's Hospital, Ulm University, Eythstrasse 24, D-89075 Ulm, Germany. simone.fulda@uniklinik-ulm.de
Nature Reviews. Drug Discovery
|May 15, 2010
Summary
Mitochondria, vital for cell energy, also trigger cell death. Targeting cancer cell mitochondria by disrupting their altered metabolism or inducing membrane permeabilization shows therapeutic promise.
Area of Science:
- Cell Biology
- Biochemistry
- Cancer Research
Background:
- Mitochondria function as the cell's energy producers and regulators of programmed cell death (apoptosis).
- Mitochondrial outer membrane permeabilization releases proteins that trigger apoptosis and impairs cellular energy production.
- Cancer cells exhibit altered mitochondrial metabolism, diverting resources from energy production to anabolic processes.
Purpose of the Study:
- To explore the dual role of mitochondria in cellular energy production and apoptosis.
- To investigate the potential of targeting mitochondrial pathways for cancer therapy.
- To examine the implications of deregulated mitochondrial metabolism in cancer cells.
Main Methods:
- Analysis of signal transduction pathways converging on mitochondria.
- Investigation of mitochondrial outer membrane permeabilization.
- Study of metabolic alterations in cancer cell mitochondria.
- Evaluation of therapeutic strategies targeting mitochondrial functions.
Main Results:
- Signal transduction pathways converge on mitochondria to induce outer membrane permeabilization and apoptosis.
- Cancer cells reprogram mitochondrial metabolism for anabolic growth, deviating from oxidative phosphorylation.
- Mitochondrial dysfunction impairs bioenergetic capacity in cancer cells.
Conclusions:
- Targeting cancer-specific mitochondrial metabolic alterations offers a potential therapeutic strategy.
- Stimulating mitochondrial membrane permeabilization can activate cell death pathways in cancer.
- Mitochondria represent a promising target for novel cancer treatments by modulating cell death and metabolism.
Related Concept Videos
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

